eek

Kobe University Repository : Kernel

fone ™

PDF issue: 2025-10-07

Relaxin has anti-apoptotic effects on human

trophoblast-derived HTR-8/SV neo cells

LODHI ROMANA SHER ZAMAN

(Degree)
et (E¥)

(Date of Degree)
2013-09-25

(Resource Type)
doctoral thesis

(Report Number)
FA 59825

(URL)
https://hdl. handle. net/20. 500. 14094/D1005982

 

K BAV TV VAMRASOF-MRRCT. RAR - PERASSRACES. SHEA CROSON TU SHAAT, OK CHAK ESL.

 

 

 

 

 

      
 

KOBE

AY
I


(ReeL BR)

Um COA R ES

Relaxin has anti-apoptotic effects on human trophoblast-derived
HTR-8/SV neo cells

VAXYVILE KhERT TA bE ATRS/SV neo MOT H b—Y AMIE
BATS

HAAKEKFRESORA EASE
BARARS
MBA WH BA Bde

Lodhi Romana Sher Zaman

Relaxin has anti-apoptotic effects on human trophoblast-derived
HTR-8/SV neo cells

The study was conducted to evaluate the effects of human relaxin on apoptosis in

~ the human trophoblast derived HTR-8/SV neo cell line, which is a possible model of

human extravillous trophoblasts (EVTs). HTR-8/SV neo cells, cultured in phenol red
free RPMI1640 medium, were treated with different doses of human recombinant (fH2)
relaxin in serum-deprived conditions. RT-PCR was used for evaluating relaxin receptor:
RXFPi and RXFP2 expression in HTR-8/SV neo cells. The cell death was examined by
TUNEL assay. Furthermore, we investigated caspase-3, cleaved PARP, and Bel-2
expressions by Western blot analysis to recognize the translational effects of anti-
apoptotic and pro-apoptotic proteins. RXFP1 and RXFP2 mRNA expression was

observed in HTR-8/SV neo cells. Compared with untreated control cultures, treatment

’ with rH2 relaxin, decreased TUNEL-positive rate in HTR-8/SV neo cells was observed.

Western blot analysis revealed that treatment with rH2 relaxin decreased the expression
of caspase-3 and cleaved PARP, but in contrast increased Bcl-2 expression in those cells.
These results suggest that rH2 relaxin has anti-apoptotic effects on HTR&/SV neo cells by
decreasing pro-apoptotic caspase-3 and cleaved PARP expression and up-regulating anti-

apoptotic Bel-2 expression.


BR

YRRVVIX, 1926 4 Hisaw FL Si ko THR TORL URLS, GRPORAEES
PROSHPARDS EMFSNED TEM 6,000 DN TF PRL EY CHS, TY ROR
B72 BER AM OT BAROMK, HRMOMAGS EA ORE KS D< T
StF, FE ARORE, DLP ROMMR CBRE SIC DO, MIR OIC
BRVEY ChE LBA ENTS, TIATCH, IFFY VERSIE, BACHE
SHAR L Lb PREM S, —H ERY PYAR EL 0 PICS
a, LHsurge #9~10 HA LD ERED, HCG LRH 10 CRAM PREER

LEI, PRR E b DICER 24 BIC CROCE, AR 36 WIC CLR

FS. PHRPOe hi PY FEY VRE OA, Fy bh. SH OPM L O BH 10045
BVO EBROMLAY, VUFSYYOPAMMIC Lo CRB TWS LHERENCHS,
ERY PRY VIL, EVEN Ch SBIRUOHC, JAR, BSS CHES L, BEIBAS
FBR, TAO LPUARARICB STS — LER SN CREM, th COU DRY YORE
HELE MBB VY, & SI, 2002, RXFP1 & RXFP2BY PHY YSRKCHS TE
PERENSE CORE, J FX LVS ophanligand ChoeRO, UV FRY VERE

OPED AREA DS ARE C 2 7k, AUPFE CHL, RXFPI & RXFP2 HEBER S & hipaCH A

Ly. BIZ FEY Y OMEN bORT IA CHAAR BERATS,

RUT ZA bicid, MBE h ATT % bO cytotrophoblast, syncytiotrophoblast L BK
RBA T SREM b AAT FA bextravillous trophoblast: EVI) S, EVT ew «
RAL MBHESH UCHR OBI RIC BERS Ric L, MO EVT HE BERBE
YER FICRA L trophoblastic cleft SIGRL. Ahi EMEA Y Ate, AMIE CE
EVT OF Rb—-VAMMOD TBR Y FY ETOLZRRBVDIC DSP ERTT
SrLITLY, placentation (2Si5 SY FH YY L EOBBER (RXFPI L RKFP2ORREH
SANT SI LRAMTHS,

BR 5

AAVREO Tsang BLEYO, Ch EVT EF VLASE bh hERS IA bAKO HTR-
B/SV neo cell line DHEA THERE > 7, RT-PCR BICC, HTR-8/SV neo cell line (
RXFP1 & RXFP2 mRNA HEBER Le, HTR-8/SV neo cell line DAMIER IC x OW
EOE bY SYEFY hUPeYY (01,03, LO ngiml) BRM LE. FRR ACBL
THE, TUNEL RICKY, MEME COT HR bY ABER SIRNA TS, HIE
FRI, 7 Rh VY APERF (caspase-3) BLOT K b—-Y 2 MAF Bel-2) ORB RR
KRETHBEY pe APV TO y bic CMH LIC. & BIC, cleaved poly(ADP-ribose)
polymerase (PARP) A38SC RST BBS Ye Ae YS ay MRICT EU aed
YFXY ARABIC, BRIN Lic, HE LOARBIA, one-way ANOVA BLU
Tukey © HSD RAEI CPP Lc

E

HTR-8/SV neo cell line i& RXFP1 & RXFP2mRNA BABEBHe, TUNEL CI. VF¥Y
VIER LT XY PRE TIL, HTR-8/SV neo cell line COT ® h—-Y ABE
MICA BRD CBD, VRAKVI AY METS, YF VY FMRIT ERE L TOY
FRY LYRE CL, HTR-8/SV neo cell line COA B72 caspase-3 HALL cleaved PARP O1E
FrEmbd, A, Bel-2 BATLARRMMEBD ic,

SR

RAWMHT, VFXY VILE b hOMTTI A b AH HTRS/SV neo MMOT HK b-Y Ai
MMREAT SX LER SINCLE, YF VIER ORI ARIEL, ER
MEPIS KL ARS MBA,

ASO + RID BHI2 U OLR EROS & L bic, Eh COLREMMO MMR
KTR PAS OY DD CHE CSC LDH L CE TS, ARIAT Cid, BE
PROBA ST OA AT VEER YO, CHUCK O BRIM ICM < . APSE L
KO, U FEY Y ORICA L OBES, CRAIG COS EBA ONS, Las
Ly RRBIO 7 2 ACH, RAV RRC, HEED To FAS oY ORS COG
BIC kK SEROMA ME CHS. ADWAFL LTO FRY YER COBEB LE
CHEB, SIDA Y Ab 94 VBE UC, BI CRATER L TS
HERDS, TOFAF VICE D BRIT SY De SL BER ANS RE
BOOB, SUFAF AYE VFR YY OMAMRICOV TH, SRORNBYBLSAD
nod.


BPAEKEREFROAR (SLR)

| BeOS: OD ES OD BES

LODHI ROMANA SHER ZAMAN

   
     

 

  

Relaxin has anti-apoptotic effects on human
trophoblast-derived HTR-8/SV neo cells

 
 
  

VAEYVUILE bh ORT A bh ATR-S/SV neo MAD
TRY AMM RE ATS

 
   
 
 
 
 
 

 

ont hvanines WW FEA _
me SRR ae
Vice-examiner .
Bl # ye. ae on we 9

Vice-examiner

       

(BSti1, 000F~2, 0008)

  
 

 

  

(84)

YPXVVIL, 1926 FE Hisaw FL SIC ho CHRHORLYU BRAK, GEPOMEE
BEBOSPFARSS CBSESNEA FEM 6,000 ON TF PHVEY CHS, TIA
ORR 72 EER AM OF SROKA, DHRAOMARSEROREBERK
bD< TOA, FE ROR, Di FROMAT EMREENTHY , HIRES -
PMICBBRHVEY CHELBAON WS, TIACE, VIXY YESH
PBA CEE S ARIEL COI PRESS, A. EU Te Y VILE
LY MAIC WS NH, LH surge #I~10 HA KY LASBW, hCG & RIT HEHE 10
CHAO ML PRE A LIB, CORRE L Lb CHER 24 IC CRATE,
36 WIA CHLAT 5S. RPO hi PU SRY UBER OR, Gy bh. Tz
O fh. PRA EY bA 100 PHEW OL BADLY, USE YY OPRAMMICLOTHR
RoOTWSLHREN WS, ELV FH YY, ERB Ch SRA,
aE, BUSA CBRL, BEND SHIR, THRO SADRBERIT BSF 3 x LASHER S
NCEER, Eb COU FEY Y OLBEAIIAMR ABS, & SIZ, 2002  RXFP1
& RXFP2 BY FRY YRAKCHSOILEBRENSZECORVE, URRY YI
orphan ligand Ch o.kkO, UFEY YEA ORM ARR Cho, BOPE
“Cha, RXFP1 & RXFP2 BBE MYS C AMRIT A L. IY PHY VY OREN bh OAT
DATE ASRBCRNT S.

haRTSA hc RB b ATF A hO cytotrophoblast, syncytiotrophoblast
& SAGER BAT ORBEA b OAT TZ b (extravillous trophoblast: EVT) dH
Sq BVT hee ALM SMES L CRM ORE RIC BERRMS REL. —
HO EVT (LAER ICA L trophoblastic cleft 2HVRL. BAme RBM
ARO AT, AOECH EV OF R b-Y RAMMOD FMR FRY LYLetORRa
BODILY S MART SILT EY, placentation CBS) FH#VYYLEORE

*#& (RXFP1 & RXFP2) ORAS SBITTS I LBANWCHS,

 
   
     
   
   
     
   
   
     
   
   
   
   
   
   
   
   
   
   
   
   
 
 

  

(7%)

AF OKO Tsang BRKY, th VT SFVL BSE hhEARTFFALAKO
HTR-8/SV neo cell line DHL SIT PRRRL1T 7. RI-PCR IZ TC, HTR-8/SV neo
cell line (< RXFP1 & RXFP2 mRNA BHLERN Lic. HIR-8/SV neo cell line ORME
BARCHA OREO’ KV SYEFY hUDHYY (0.1, 0.3, LOng/al) RMLE,
FR b- VAL CA, TUNEL RIT EO, REM COT RK bY AGERE
BUCS 5. KCB, TAN bh YARRA (caspase-3) LUT M b—-Y AH

 
   
     
     


 

iil AF (Bcl-2) DH ARSC RET RBA eae VT uy ME CRHLE KOR,
cleaved poly (ADP-ribose) polymerase (PARP) BASIC RISTHRBS Ve rzevT
By MAIC, ERU SAVED Y bY PSY RAC, BRIAN LIC, BEBE
LOABBIT, one-way ANOVA BE U Tukey © HSD RIE CHP LA.

(ER)

HTR-8/SV neo cell line (< RXFP1 & RXFP2 mRNA AHH 7, TUNEL HCH. VF
AY V SERRE RR LY Fe RAE Chk, HTR-8/SV neo cell line COTA hb
VARMA REBL EBD, VeAPYS Uy hRCK YU FEY UIE
PICHRL TY DH Y LRM Tid, HTR-8/SV neo cell line COMM? caspase-3 %
BL cleaved PARP OK FER, —H, Bel-2 BACIARRMSERHE,

[42] .
BAWMOT. VFRYVILE bh haRTF A b HE HTRE/SV neo MID T A b—Y |
AMABRLATSILRHSMIZLE, UFXY VERT ORBERICEALA
Ly, FERRER < MEARS HBSHE,

BASE - DURIDBHIZ2 LO LFA EROMARL LIT, ch CORDON
WRIT PAF YB CRE CHS TH LDH LTE CWS, LRN 7REET
CL, HREOKKDS Sa PAF OY BERBIY, CHICK 0 BRET <.
AMG LICKO, VIFVYOMRCBAL OBES, HIRAI COS LS
ABNS, LOL. RABBBOT UCAS, BABAR, HAEOP AFR
FUYORS CHAR L SHROMREDAH CHS, ADWRFLEL TOU FH YY -
RA COBERYECHSOR, APIF4Y + A-bI PAV RFE UT, BBE
ECHR LTS AER DS, SOFAFOVICK O MBBICBMI SY De
VV BERGE SNS ERS SOR, PASAT AUYLY IXYYOMEMERICOW
Th, FRORNBLELEZ ONS,

ATFRUL, PRO O RIOR - CORRS TSR EVIOUT, SAF
ATF AY YRORVEVIZOWCHELE DD CHEB, FERIELA EMITTED
DEV IRV YOTR bY AEA OW CBERARESE LOL UL CMEDS
RMCHELRDOS, Lot, AHHH, Bt (EF) OFMERORBRSSOLB
oS.

 

 


